Edition:
United States

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

2.26USD
18 Jan 2019
Change (% chg)

$0.12 (+5.61%)
Prev Close
$2.14
Open
$2.15
Day's High
$2.38
Day's Low
$2.15
Volume
55,894
Avg. Vol
38,227
52-wk High
$4.56
52-wk Low
$1.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.04 -0.045
Jun '18 0.09 -0.041
Mar '18 0.15 -0.047
FY 2017 Dec '17 0.11 -0.060
Sep '17 0.03 -0.086
Jun '17 0.01 -0.052
Mar '17 0.08 -0.057
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta 0.85 1.08 0.90
Price to Sales (TTM) 1,110.25 49.51 6.28
Price to Book (MRQ) -- 10.16 5.27
Price to Tangible Book (MRQ) -- 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 5.90 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -93.70 130.03 9.72
Sales (TTM) vs TTM 1 Yr. Ago -42.39 47.85 5.87
Sales - 5 Yr. Growth Rate -38.07 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 37.65 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago 55.50 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -39.54 9.24 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.94 2.18 2.26
Current Ratio (MRQ) 0.94 3.43 3.08
LT Debt to Equity (MRQ) -- 18.73 11.38
Total Debt to Equity (MRQ) -- 31.43 16.13
Interest Coverage (TTM) -88.90 -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 15.24 56.29 53.78
Gross Margin - 5 Yr. Avg. 89.96 60.55 52.17
EBITD Margin (TTM) -6,209.52 -- --
EBITD - 5 Yr. Avg -383.86 -110.23 12.87
Operating Margin (TTM) -6,210.97 -184.42 6.20
Operating Margin - 5 Yr. Avg. -384.15 -126.67 8.31
Pre-Tax Margin (TTM) -6,370.48 -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -387.78 -132.83 8.61
Net Profit Margin (TTM) -6,370.48 -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -387.36 -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 45,045 7,650,695 844,239,566
Net Income/Employee (TTM) -2,869,585 652,572 100,064,145
Receivable Turnover (TTM) 12.23 6.25 5.72
Inventory Turnover (TTM) 8.87 1.89 3.48
Asset Turnover (TTM) 0.21 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -1,329.05 6.45 11.08
Return on Assets - 5 Yr. Avg. -530.60 5.52 12.21
Return on Investment (TTM) -- 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.85 15.88
Return on Equity (TTM) -- 10.13 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -89.73 -56.13 -38.07
EPS (TTM) % 40.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nymox Pharmaceutical Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.14 -1.38 49 99
13 Week -7.51 -12.01 36 95
26 Week -6.37 -13.49 44 98
52 Week 19.75 1.50 64 72
YTD 43.07 25.65 70 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.57%
# of Holders: 72
Total Shares Held: 4,185,258
3 Mo. Net Change: -121,712
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 3
# Reduced Positions: 4
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.